These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1931468)

  • 1. Disposition and tumour concentrations of platinum in hypoalbuminaemic patients after treatment with cisplatin for cancer of the head and neck.
    Holding JD; Lindup WE; Bowdler DA; Siodlak MZ; Stell PM
    Br J Clin Pharmacol; 1991 Aug; 32(2):173-9. PubMed ID: 1931468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of a cisplatin-albumin complex for the treatment of cancer of the head and neck.
    Holding JD; Lindup WE; van Laer C; Vreeburg GC; Schilling V; Wilson JA; Stell PM
    Br J Clin Pharmacol; 1992 Jan; 33(1):75-81. PubMed ID: 1540494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and tumor concentration of intraarterial and intravenous cisplatin in patients with head and neck squamous cancer.
    Sileni VC; Fosser V; Maggian P; Padula E; Beltrame M; Nicolini M; Arslan P
    Cancer Chemother Pharmacol; 1992; 30(3):221-5. PubMed ID: 1628371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of intra-arterial and intravenous cisplatin in head and neck cancer patients.
    Gouyette A; Apchin A; Foka M; Richard JM
    Eur J Cancer Clin Oncol; 1986 Mar; 22(3):257-63. PubMed ID: 3709595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor concentration of platinum in patients with head and neck cancer.
    Mattox DE; Sternson LA; Von Hoff DD; Kuhn JG; Repta AJ
    Otolaryngol Head Neck Surg; 1983 Jun; 91(3):271-5. PubMed ID: 6410327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetic of platin in plasma and urine of man under 1-, 8-, and 24 h-infusion with cis-dichlorodiamine-platin (II) (cis-DDP) (author's transl)].
    von Heyden HW; Henkel H; Nagel GA; Weinstock N
    Klin Wochenschr; 1982 Mar; 60(5):247-55. PubMed ID: 7200547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin pharmacokinetics and pharmacodynamics in patients with squamous-cell carcinoma of the head/neck or esophagus.
    Johnsson A; Höglund P; Grubb A; Cavallin-Ståhl E
    Cancer Chemother Pharmacol; 1996; 39(1-2):25-33. PubMed ID: 8995496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of liposomal cisplatin (lipoplatin) in combination with 5-FU in patients with advanced head and neck cancer: first results of a phase III study.
    Jehn CF; Boulikas T; Kourvetaris A; Possinger K; Lüftner D
    Anticancer Res; 2007; 27(1A):471-5. PubMed ID: 17352269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum in blood mononuclear cells from patients after cisplatin therapy.
    Sunderman FW; Sporn J; Hopfer SM; Sweeney KR; Chakraborty NG; Greenberg B
    Ann Clin Lab Sci; 1990; 20(6):379-84. PubMed ID: 2073087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin based chemotherapy in testicular cancer patients: long term platinum excretion and clinical effects.
    Hohnloser JH; Schierl R; Hasford B; Emmerich B
    Eur J Med Res; 1996 Sep; 1(11):509-14. PubMed ID: 9438151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of cis-dichlorodiammineplatinum (II)].
    Horiuchi M; Inuyama Y; Kohno N; Mashino S; Fujii M
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):632-7. PubMed ID: 6892197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoural administration of cisplatin in slow-release devices: II. Pharmacokinetics and intratumoural distribution.
    Deurloo MJ; Kop W; van Tellingen O; Bartelink H; Begg AC
    Cancer Chemother Pharmacol; 1991; 27(5):347-53. PubMed ID: 1998994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck.
    Baselga J; Trigo JM; Bourhis J; Tortochaux J; Cortés-Funes H; Hitt R; Gascón P; Amellal N; Harstrick A; Eckardt A
    J Clin Oncol; 2005 Aug; 23(24):5568-77. PubMed ID: 16009950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous infusion of high-dose cisplatin in children: pharmacokinetics of free and total platinum.
    Bues-Charbit M; Gentet JC; Bernard JL; Breant V; Cano JP; Raybaud C
    Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1649-52. PubMed ID: 3428333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake and retention of platinum in patients undergoing cisplatin therapy.
    Jonson R; Börjesson J; Mattsson S; Unsgaard B; Wallgren A
    Acta Oncol; 1991; 30(3):315-9. PubMed ID: 2036240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between hematotoxicity and serum albumin level in the treatment of head and neck cancers with concurrent chemoradiotherapy using cisplatin.
    Ishizuka M; Fujimoto Y; Itoh Y; Kitagawa K; Sano M; Miyagawa Y; Ando A; Hiramatsu M; Hirasawa N; Ishihara S; Nakashima T; Yamada K
    Jpn J Clin Oncol; 2011 Aug; 41(8):973-9. PubMed ID: 21693483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular pharmacokinetic/pharmacodynamic relationship of platinum cytostatics in head and neck squamous cell carcinoma evaluated by liquid chromatography coupled to tandem mass spectrometry.
    Theile D; Detering JC; Herold-Mende C; Dyckhoff G; Haefeli WE; Weiss J; Burhenne J
    J Pharmacol Exp Ther; 2012 Apr; 341(1):51-8. PubMed ID: 22207655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo.
    Welters MJ; Fichtinger-Schepman AM; Baan RA; Jacobs-Bergmans AJ; Kegel A; van der Vijgh WJ; Braakhuis BJ
    Br J Cancer; 1999 Jan; 79(1):82-8. PubMed ID: 10408697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of intra-arterial and intravenous infusion of cisplatin for head and neck squamous cell carcinoma in a modified rat model.
    Moses BL; Chan DW; Hruban RH; Forastiere A; Richtsmeier WJ
    Arch Otolaryngol Head Neck Surg; 1993 Jun; 119(6):612-7. PubMed ID: 8499090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretion.
    Belliveau JF; Posner MR; Ferrari L; Crabtree GW; Cummings FJ; Wiemann MC; O'Leary GP; Griffin H; Phaneuf MA; O'Rourke A
    Cancer Treat Rep; 1986 Oct; 70(10):1215-7. PubMed ID: 3756943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.